学术探索
学术期刊
新闻热点
数据分析
智能评审

Chronic myeloid leukemia

被引：1137
作者：
Sawyers, CL
机构：
[1] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1999年 / 340卷 / 17期
关键词：
D O I：
10.1056/NEJM199904293401706
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1330 / 1340
页数：11
相关论文
共 100 条
[91]   Role of interleukin-2 in human hematological malignancies [J].
Toren, A ;
Ackerstein, A ;
Slavin, S ;
Nagler, A .
MEDICAL ONCOLOGY, 1995, 12 (03) :177-186
[92]  
TURA S, 1994, NEW ENGL J MED, V330, P820
[93]   THE MOUSE TYPE-IV C-ABL GENE-PRODUCT IS A NUCLEAR-PROTEIN, AND ACTIVATION OF TRANSFORMING ABILITY IS ASSOCIATED WITH CYTOPLASMIC LOCALIZATION [J].
VANETTEN, RA ;
JACKSON, P ;
BALTIMORE, D .
CELL, 1989, 58 (04) :669-678
[94]   Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation [J].
vanRhee, F ;
Szydlo, RM ;
Hermans, J ;
Devergie, A ;
Frassoni, F ;
Arcese, W ;
deWitte, T ;
Kolb, HJ ;
Niederwiser, D ;
Jacobsen, N ;
Gahrton, G ;
Bandini, G ;
Carreras, E ;
Bacigalupo, A ;
Michallet, M ;
Ruutu, T ;
Reiffers, J ;
Goldman, JM ;
Apperley, J ;
Gratwohl, A .
BONE MARROW TRANSPLANTATION, 1997, 20 (07) :553-560
[95]   BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients [J].
Verfaillie, CM ;
Bhatia, R ;
Miller, W ;
Mortari, F ;
Roy, V ;
Burger, S ;
McCullough, J ;
Stieglbauer, K ;
Dewald, G ;
Heimfeld, S ;
Miller, JS ;
McGlave, PB .
BLOOD, 1996, 87 (11) :4770-4779
[96]  
VONCKEN JW, 1992, BLOOD, V79, P1029
[97]   BCR/ABL P210 AND P190 CAUSE DISTINCT LEUKEMIA IN TRANSGENIC MICE [J].
VONCKEN, JW ;
KAARTINEN, V ;
PATTENGALE, PK ;
GERMERAAD, WTV ;
GROFFEN, J ;
HEISTERKAMP, N .
BLOOD, 1995, 86 (12) :4603-4611
[98]   ANTI-LEUKEMIC EFFECT OF CHRONIC GRAFT VERSUS HOST-DISEASE - CONTRIBUTION TO IMPROVED SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION [J].
WEIDEN, PL ;
SULLIVAN, KM ;
FLOURNOY, N ;
STORB, R ;
THOMAS, ED .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (25) :1529-1533
[99]   Identification of the abl- and rasGAP-associated 62 kDa protein as a docking protein, dok [J].
Yamanashi, Y ;
Baltimore, D .
CELL, 1997, 88 (02) :205-211
[100]  
Zuffa E, 1998, HAEMATOLOGICA, V83, P231
12345678910